We use cookies, just to track visits to our website, we store no personal details.
Learn More
Accept
Essential Medicines & Vaccines
Admin Home
User Management
My Profile
Regional Users
Countrywide Users
Setup
Organisations
Locations
Manufacturers
Health Facilities
Therapeutic Areas
Medicine Class
Generic Names
Dosage Strength
Dosage Form
Package Size
Funding Source
Regional Dashboards
Health Facilities
Registered Premises
Local Manufacturers
Registered Products
Pharmacovigilance
Good Manufacturing Practices
Quality Control Labs
Regional Data
Registered Premises
Local Manufacturers
Registered Products
Good Manufacturing Practices
Quality Control Labs
Product Stocks
Country Profile
Stock Summary
Stock Status
Stock Pipeline
Inventory Control
Stockout Trend
Shipment Reports
Content Manager
News
Upcoming Event
Alerts
Photo Gallery
Video Gallery
Notifications
Document Manager
Guidelines & Manuals
SOPs & Templates
Expression of Interests
Publication
Library
Feedbacks
Profile
Change Password
Messages
Logout
Lang
English
French
Portuguese
Back to List
Edit
Active Ingredient
Generic Name
Therapeutic Area
Select...
Anti-Malaria
HIV Infections and Related Diseases
Anti-Tuberculosis
Neglected Tropical Diseases (NTD)
Antibacterial Medicine
Reproductive Health
Life-Saving Medicines
Biological Products (Vaccines & Immune Globulins)
Class
Select...
Antiretrovirals as co-packaged formulations for adults and adolescents
Antiretrovirals as fixed-dose combinations (FDC) for adults and adolescents
Antiretrovirals as fixed-dose combinations (FDC) for paediatric use
Antiretrovirals as single-ingredient formulations for use in adults and adolescents
Antiretrovirals as single-ingredient formulations for use in adults and adolescents
Antiretrovirals as single-ingredient formulations for use in children
Antivirals as fixed-dose combinations (FDC) for adults and adolescents
Antivirals as single-ingredient formulations for use in adults and adolescents
Antivirals as single-ingredient formulations for use in children: Paediatric formulations
Reverse-transcriptase inhibitors (RTIs)
Description
Dosage Form
Select...
Tablet
Capsule
Powder for Injection
Dusting Powder
Cream
Paste
Gel
Suppository
Syrup
Oral Solution
Emulsion
Suspension
Inhaler
Aerosois
Infusion
Tablet, Dispersible
Tablet, Film-coated
Oral Powder
Mosquito Net
Injections
Spray
Eye/Ear Drops
Ointment
Skin Solution
Inhalation Anesthetic
Oral Suspension
Scable Tablet
Soft Capsule
Parental
Injectable ampoule
Ovum
Ophthalmic Ointment
Powder for Oral Suspension
Solution for Injection Infusion
Extended Release Tablet
Powder for Solution for Injection in Vial
Dispersible Tablet
Film-Coated Tablet
Sustained Release Tablet
Strength
Select...
50mg/5ml
175MG/174MG/204MG264MG
100ml
75mg
0.52g/0.30g/0.58g/(2.7g/200ml)
1000mg/100ml
5mg/ml
500mg
500mg 125mg
500 mg/125 mg
250 mg/62.5 mg
20ml
Route of Administration
Select...
Intravenous
Intraosseous
Endotracheal
Inhalation
Sublingual
Intramuscular
Subcutaneous
Rectal
Oral
Transdermal
Status
Select
Active